CD247 and graft versus host disease: Of note, high mortality rates were reported only in the xenograft group treated with the CD3ζ-based NKG2DL-redirected CAR-Ts which was a result of graft-versus-host disease (GvHD), as higher levels of serum cytokines were documented in this experimental group (128).